Back to Search
Start Over
Comprehensive metabolic profiles of Achyranthes bidentate in rat serum via ultra-high performance liquid chromatography time-of-flight mass spectrometry and their correlation with osteoinductive activity.
- Source :
-
Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2023 Jul 05; Vol. 231, pp. 115418. Date of Electronic Publication: 2023 Apr 24. - Publication Year :
- 2023
-
Abstract
- The osteoinductive effect of crude and salt-processed Achyranthes bidentata is associated with the serum metabolites. Grey relationship analysis between the serum metabolites and osteoinductive effect will help to clarify the bioactive serum metabolites. First, an ultra-high performance liquid chromatography time-of-flight mass spectrometry method was used to develop serum metabolic fingerprint of rats after oral administration of crude and salt-processed Achyranthes bidentata. The MS <superscript>1</superscript> and MS <superscript>2</superscript> data of serum metabolites were scanned in the range of m/z 100-1500 and 50-1200, respectively. The chemical structures of the metabolites were thoroughly elucidated. Two prototypes and twelve metabolites have been identified. Second, osteoblasts were cultured with the drug-containing serum at different time points. The osteoinductive effect of crude and salt-processed Achyranthes bidentata was evaluated by detecting the proliferation rate and alkaline phosphatase activity of osteoblasts. Third, grey correlation analysis was utilized to elucidate the spectral-effect relationship between serum metabolic fingerprints and osteoinductive effect. Finally, the correlation coefficients of ten metabolites, i.e., oleanolic acid, poststerone-M1, chikusetsusaponin V-M1, oleanolic acid-M2, oleanolic acid-M4, spinacoside D-M1, chikusetsusaponin I-M1, betavulgaroside IV-M2, chikusetsusaponin IVa and achyranthoside IV-M1 were above 0.7. Collectively, our work will provide helpful knowledge for the future research on Achyranthes bidentata.<br />Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2023 Elsevier B.V. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1873-264X
- Volume :
- 231
- Database :
- MEDLINE
- Journal :
- Journal of pharmaceutical and biomedical analysis
- Publication Type :
- Academic Journal
- Accession number :
- 37116317
- Full Text :
- https://doi.org/10.1016/j.jpba.2023.115418